Wilmington, DENCT07412002Now EnrollingIRB Ready

Childhood Hematopoietic and Lymphatic System Neoplasm Clinical Trial in Wilmington, DE

Access cutting-edge childhood hematopoietic and lymphatic system neoplasm treatment through this clinical trial at a research site in Wilmington. Study-provided care at no cost to qualified participants.

Sponsored by Children's Oncology Group

Quick Self-Assessment

See if you qualify for this Wilmington location

Preparing your pre-screening questions…

Expert Care in Wilmington

Access childhood hematopoietic and lymphatic system neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related childhood hematopoietic and lymphatic system neoplasm treatment provided free

Apply for This Wilmington Location

Check if you qualify for this childhood hematopoietic and lymphatic system neoplasm clinical trial in Wilmington, DE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Wilmington

    Convenient for DE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Wilmington site if eligible
  4. 4Begin participation

About This Childhood Hematopoietic and Lymphatic System Neoplasm Study in Wilmington

This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end of life care. The data collected from this study may help researchers develop a model for identifying patients at risk of low quality end of life care as well as recommendations for potential future interventions.

Sponsor: Children's Oncology Group

Who Can Participate

Inclusion Criteria

Index Child (COG Registered Patient):
Must be deceased
\< 18 years old at time of death
Diagnosed with any oncologic condition
History of enrollment on Stratum 1 of APEC14B1, Project:EveryChild
Note: history of treatment on a COG therapeutic trial is not required
Resided in the United States, including Puerto Rico, as evidenced by most recent address, at the time of death Bereaved Parent(s):
Must be a parent, legal guardian, or caregiver (biological or non-biological) of an eligible Index Child enrolled on APEC14B1 with current Consent to Future Contact (e.g., from the APEC14B1 Part B Consent)
Self-reported confirmation of familiarity with the care received by the Index Child in the last month of their life
Bereaved parent must understand English or Spanish (written and/or spoken)
Must be a parent/guardian/key contact from the Index Child's APEC14B1 Future Contact study record or must be referred by one of the APEC14B1 contacts
Bereaved parent must be \>= 18 years old at the time of ALTE24C1 study enrollment Regulatory Requirements:
Bereaved parent must provide verbal or implied informed consent
For all participants, all institutional, FDA, and NCI requirements for human studies must be met

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Wilmington?

Yes, this clinical trial (NCT07412002) has an active research site in Wilmington, DE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Childhood Hematopoietic and Lymphatic System Neoplasm Treatment Options in Wilmington, DE

If you're searching for childhood hematopoietic and lymphatic system neoplasm treatment options in Wilmington, DE, this clinical trial (NCT07412002) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Wilmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced childhood hematopoietic and lymphatic system neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all childhood hematopoietic and lymphatic system neoplasm clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Wilmington, DE

See all essential tremor clinical trials recruiting in Wilmington — not just this study.

Browse Essential Tremor Trials in Wilmington →

Browse More Trials by Condition

Essential Tremor TrialsAnkylosing Spondylitis TrialsPulmonary Hypertension TrialsInterstitial Cystitis TrialsInterstitial Lung Disease TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Wilmington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Wilmington, DE